Lataa...
Incidence and Impact of Persistent Viremia on SVR Rates in Patients Receiving Direct-Acting Antiviral Therapy
Rates of persistent viremia (PV) while on direct-acting antiviral therapy were low (5.7%) in a real-world cohort of 983 patients. High sustained virologic response rates were achieved both in patients with PV (92.9%) and those with rapid virologic response (96.5%), without significant differences.
Tallennettuna:
| Julkaisussa: | Open Forum Infect Dis |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7770330/ https://ncbi.nlm.nih.gov/pubmed/33409333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa569 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|